Publications

2023

Reply: Novel antidiabetic drugs and the risk for HCC. What else to expect from these "wonderful" drug classes?Plaz Torres MC, Jaffe A, Perry R, Marabotto E, Strazzabosco M, Giannini EG. Hepatology. 2023 Jun 1; 2023 Feb 3. PMID: 36724446.
Fibroblasts to hepatocytes: A nonstop flight into cell therapy for liver diseases?Gouon-Evans V, Fiorotto R. Hepatology. 2023 May 1; 2023 Apr 17. PMID: 35957526.
Cell-matrix interactions control biliary organoid polarity, architecture, and differentiation.Fiorotto R, Mariotti V, Taleb SA, Zehra SA, Nguyen M, Amenduni M, Strazzabosco M. Hepatol Commun. 2023 Apr 1; 2023 Mar 24. PMID: 36972396.
Non-classical HLA class I molecules and their potential role in viral infections.Beltrami S, Rizzo S, Strazzabosco G, Gentili V, Alogna A, Narducci M, Bortolotti D, Schiuma G, Rizzo R. Hum Immunol. 2023 Mar 31; 2023 Mar 31. PMID: 37005169.
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma.Cadamuro M, Sarcognato S, Camerotto R, Girardi N, Lasagni A, Zanus G, Cillo U, Gringeri E, Morana G, Strazzabosco M, Campello E, Simioni P, Guido M, Fabris L. Int J Mol Sci. 2023 Mar 1; 2023 Mar 1. PMID: 36902188.
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study.Morieri ML, Raz I, Consoli A, Rigato M, Lapolla A, Broglio F, Bonora E, Avogaro A, Fadini GP. J Endocrinol Invest. 2023 Jan 9; 2023 Jan 9. PMID: 36624223.
Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCC.Jaffe A, Taddei TH, Giannini EG, Ilagan-Ying YC, Colombo M, Strazzabosco M. Liver Int. 2023 Jan; 2022 Dec 5. PMID: 36426717.
Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysis.Kayali S, Pasta A, Plaz Torres MC, Jaffe A, Strazzabosco M, Marenco S, Giannini EG. Liver Int. 2023 Jan; 2022 Sep 27. PMID: 36102312.

2022

Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?Wang Y, Strazzabosco M, Madoff DC. Curr Oncol Rep. 2022 Dec; 2022 Oct 18. PMID: 36255606.
Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook.Jaffe A, Taddei TH, Giannini EG, Ilagan-Ying YC, Colombo M, Strazzabosco M. Liver Int. 2022 Dec; 2022 Oct 11. PMID: 36161463.
Retracted: Posttranslational regulation of polycystin-2 protein expression as a novel mechanism of cholangiocyte reaction and repair from biliary damage.Hepatology. 2022 Dec; 2022 Jun 17. PMID: 35713384.
Diabetes medications and risk of HCC.Plaz Torres MC, Jaffe A, Perry R, Marabotto E, Strazzabosco M, Giannini EG. Hepatology. 2022 Dec; 2022 Mar 22. PMID: 35239194.
ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.Cillo U, Weissenbacher A, Pengel L, Jochmans I, Roppolo D, Amarelli C, Belli LS, Berenguer M, De Vries A, Ferrer J, Friedewald J, Furian L, Greenwood S, Monbaliu D, Nadalin S, Neyrinck A, Strazzabosco M, Toso C, Zaza G, Thuraisingham R, Berney T, Potena L, Montserrat N, Selzner N. Transpl Int. 2022; 2022 Oct 24. PMID: 36406781.
Molecular determinants of peri-apical targeting of inositol 1,4,5-trisphosphate receptor type 3 in cholangiocytes.Rodrigues MA, Gomes DA, Fiorotto R, Guerra MT, Weerachayaphorn J, Bo T, Sessa WC, Strazzabosco M, Nathanson MH. Hepatol Commun. 2022 Oct; 2022 Jul 19. PMID: 35852334.
The Evolution of Ketosis: Potential Impact on Clinical Conditions.Dilliraj LN, Schiuma G, Lara D, Strazzabosco G, Clement J, Giovannini P, Trapella C, Narducci M, Rizzo R. Nutrients. 2022 Sep 1; 2022 Sep 1. PMID: 36079870.
Synthesis and NLRP3-Inflammasome Inhibitory Activity of the Naturally Occurring Velutone F and of Its Non-Natural Regioisomeric Chalconoids.De Ventura T, Perrone M, Missiroli S, Pinton P, Marchetti P, Strazzabosco G, Turrin G, Illuminati D, Cristofori V, Fantinati A, Fabbri M, Giorgi C, Trapella C, Zanirato V. Int J Mol Sci. 2022 Aug 11; 2022 Aug 11. PMID: 36012241.
Bile acids and their receptors: modulators and therapeutic targets in liver inflammation.Bertolini A, Fiorotto R, Strazzabosco M. Semin Immunopathol. 2022 Jul; 2022 Apr 12. PMID: 35415765.
Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.Borde T, Nezami N, Laage Gaupp F, Savic LJ, Taddei T, Jaffe A, Strazzabosco M, Lin M, Duran R, Georgiades C, Hong K, Chapiro J. Radiology. 2022 Jul; 2022 Apr 12. PMID: 35412368.
Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma.Cadamuro M, Romanzi A, Guido M, Sarcognato S, Cillo U, Gringeri E, Zanus G, Strazzabosco M, Simioni P, Villa E, Fabris L. J Pers Med. 2022 Jun 30; 2022 Jun 30. PMID: 35887583.
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1(-/-) mouse model of congenital hepatic fibrosis.Fabris L, Milani C, Fiorotto R, Mariotti V, Kaffe E, Seller B, Sonzogni A, Strazzabosco M, Cadamuro M. FASEB J. 2022 Jun. PMID: 35593740.
Adjusting Barcelona Clinic Liver Cancer Staging System to the Evolving Landscape of Hepatocellular Carcinoma: A Look to the Future.Strazzabosco M, Cabibbo G, Colombo M. Gastroenterology. 2022 Jun; 2022 Feb 2. PMID: 35122767.
Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581].Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, Nishida N, Khor SS, Gervais O, Kawai Y, Nagasaki M, Tokunaga K, Tang R, Shi Y, Li Z, Juran BD, Atkinson EJ, Gerussi A, Carbone M, Asselta R, Cheung A, de Andrade M, Baras A, Horowitz J, Ferreira MAR, Sun D, Jones DE, Flack S, Spicer A, Mulcahy VL, Byun J, Han Y, Sandford RN, Lazaridis KN, Amos CI, Hirschfield GM, Seldin MF, Invernizzi P, Siminovitch KA, Ma X, Nakamura M, Mells GF. J Hepatol. 2022 Feb; 2021 Dec 9. PMID: 34895949.
The Neglected Role of Bile Duct Epithelial Cells in NASH.Cadamuro M, Lasagni A, Sarcognato S, Guido M, Fabris R, Strazzabosco M, Strain AJ, Simioni P, Villa E, Fabris L. Semin Liver Dis. 2022 Feb; 2021 Nov 18. PMID: 34794182.
Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention.Cadamuro M, Strazzabosco M. Adv Cancer Res. 2022; 2022 Mar 10. PMID: 35961707.

2021

GlicoPro, Novel Standardized and Sterile Snail Mucus Extract for Multi-Modulative Ocular Formulations: New Perspective in Dry Eye Disease Management.Mencucci R, Strazzabosco G, Cristofori V, Alogna A, Bortolotti D, Gafà R, Cennamo M, Favuzza E, Trapella C, Gentili V, Rizzo R. Pharmaceutics. 2021 Dec 13; 2021 Dec 13. PMID: 34959420.
Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging.Gross M, Spektor M, Jaffe A, Kucukkaya AS, Iseke S, Haider SP, Strazzabosco M, Chapiro J, Onofrey JA. PLoS One. 2021; 2021 Dec 1. PMID: 34852007.
Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion.Bortolotti D, Gentili V, Rizzo S, Schiuma G, Beltrami S, Spadaro S, Strazzabosco G, Campo G, Carosella ED, Papi A, Rizzo R, Contoli M. Viruses. 2021 Sep 17; 2021 Sep 17. PMID: 34578436.
Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients: A series of 43 cases.Kondo R, Kawaguchi N, McConnell MJ, Sonzogni A, Licini L, Valle C, Bonaffini PA, Sironi S, Alessio MG, Previtali G, Seghezzi M, Zhang X, Sun Z, Utsumi T, Strazzabosco M, Iwakiri Y. Hepatol Res. 2021 Sep; 2021 Aug 2. PMID: 34260803.
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, Nishida N, Khor SS, Gervais O, Kawai Y, Nagasaki M, Tokunaga K, Tang R, Shi Y, Li Z, Juran BD, Atkinson EJ, Gerussi A, Carbone M, Asselta R, Cheung A, de Andrade M, Baras A, Horowitz J, Ferreira MAR, Sun D, Jones DE, Flack S, Spicer A, Mulcahy VL, Byan J, Han Y, Sandford RN, Lazaridis KN, Amos CI, Hirschfield GM, Seldin MF, Invernizzi P, Siminovitch KA, Ma X, Nakamura M, Mells GF. J Hepatol. 2021 Sep; 2021 May 23. PMID: 34033851.
Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.McConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, Bonaffini PA, Sironi S, Alessio MG, Previtali G, Seghezzi M, Zhang X, Lee AI, Pine AB, Chun HJ, Zhang X, Fernandez-Hernando C, Qing H, Wang A, Price C, Sun Z, Utsumi T, Hwa J, Strazzabosco M, Iwakiri Y. J Hepatol. 2021 Sep; 2021 May 13. PMID: 33991637.
TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection.Bortolotti D, Gentili V, Rizzo S, Schiuma G, Beltrami S, Strazzabosco G, Fernandez M, Caccuri F, Caruso A, Rizzo R. Microorganisms. 2021 Aug 26; 2021 Aug 26. PMID: 34576716.
Design of Liposomes Carrying HelixComplex Snail Mucus: Preliminary Studies.Alogna A, Gentili V, Trapella C, Hallan SS, Sguizzato M, Strazzabosco G, Fernández M, Cortesi R, Rizzo R, Bortolotti D. Molecules. 2021 Aug 4; 2021 Aug 4. PMID: 34443296.
Thermal ablation alone vs thermal ablation combined with transarterial chemoembolization for patients with small (<3 cm) hepatocellular carcinoma.Chai NX, Chapiro J, Petukhova A, Gross M, Kucukkaya A, Raju R, Zeevi T, Elbanan M, Lin M, Perez-Lozada JC, Schlachter T, Strazzabosco M, Pollak JS, Madoff DC. Clin Imaging. 2021 Aug; 2021 Feb 11. PMID: 33592550.
New insights on the role of vascular endothelial growth factor in biliary pathophysiology.Mariotti V, Fiorotto R, Cadamuro M, Fabris L, Strazzabosco M. JHEP Rep. 2021 Jun; 2021 Feb 4. PMID: 34151244.
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis.Asselta R, Paraboschi EM, Gerussi A, Cordell HJ, Mells GF, Sandford RN, Jones DE, Nakamura M, Ueno K, Hitomi Y, Kawashima M, Nishida N, Tokunaga K, Nagasaki M, Tanaka A, Tang R, Li Z, Shi Y, Liu X, Xiong M, Hirschfield G, Siminovitch KA, Carbone M, Cardamone G, Duga S, Gershwin ME, Seldin MF, Invernizzi P. Gastroenterology. 2021 Jun; 2021 Mar 4. PMID: 33675743.
Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI.Doemel LA, Chapiro J, Laage Gaupp F, Savic LJ, Kucukkaya AS, Petukhova A, Tefera J, Zeevi T, Lin M, Schlachter T, Jaffe A, Strazzabosco M, Patel T, Stein SM. Eur Radiol. 2021 May; 2020 Oct 30. PMID: 33123796.
Fibrocystic liver disease: novel concepts and translational perspectives.Lasagni A, Cadamuro M, Morana G, Fabris L, Strazzabosco M. Transl Gastroenterol Hepatol. 2021; 2021 Apr 5. PMID: 33824930.
Novel approaches to liver disease diagnosis and modeling.Oliveira AG, Fiorotto R. Transl Gastroenterol Hepatol. 2021; 2021 Apr 5. PMID: 33824923.
Rare and undiagnosed liver diseases: challenges and opportunities.Fabris L, Strazzabosco M. Transl Gastroenterol Hepatol. 2021; 2021 Apr 5. PMID: 33824922.
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic.Cadamuro M, Lasagni A, Lamarca A, Fouassier L, Guido M, Sarcognato S, Gringeri E, Cillo U, Strazzabosco M, Marin JJ, Banales JM, Fabris L. Expert Opin Investig Drugs. 2021 Apr; 2021 Feb 23. PMID: 33622120.
IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.Stein S, Henze L, Poch T, Carambia A, Krech T, Preti M, Schuran FA, Reich M, Keitel V, Fiorotto R, Strazzabosco M, Fischer L, Li J, Müller LM, Wagner J, Gagliani N, Herkel J, Schwinge D, Schramm C. J Hepatol. 2021 Apr; 2020 Nov 13. PMID: 33197512.
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.Sirica AE, Strazzabosco M, Cadamuro M. Adv Cancer Res. 2021; 2020 Dec 9. PMID: 33579427.
The Tumor Microenvironment in Cholangiocarcinoma Progression.Fabris L, Sato K, Alpini G, Strazzabosco M. Hepatology. 2021 Jan; 2020 Nov 6. PMID: 32500550.

2020

Health related quality of life in chronic liver diseases.Cortesi PA, Conti S, Scalone L, Jaffe A, Ciaccio A, Okolicsanyi S, Rota M, Fabris L, Colledan M, Fagiuoli S, Belli LS, Cesana G, Strazzabosco M, Mantovani LG. Liver Int. 2020 Nov. PMID: 32851764.
Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis.Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G. Hepatology. 2020 Nov; 2020 Oct 20. PMID: 32702162.
Value-based medicine, a compass to guide healthcare decisions in the COVID-19 aftermath.Strazzabosco M. Liver Int. 2020 Sep. PMID: 32677111.
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Nat Rev Gastroenterol Hepatol. 2020 Sep; 2020 Jun 30. PMID: 32606456.
Liver Matrix in Benign and Malignant Biliary Tract Disease.Fabris L, Cadamuro M, Cagnin S, Strazzabosco M, Gores GJ. Semin Liver Dis. 2020 Aug; 2020 Mar 11. PMID: 32162285.
Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?Plaz Torres MC, Bodini G, Furnari M, Marabotto E, Zentilin P, Strazzabosco M, Giannini EG. Cancers (Basel). 2020 May 31; 2020 May 31. PMID: 32486355.
The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases.Cadamuro M, Girardi N, Gores GJ, Strazzabosco M, Fabris L. Front Med (Lausanne). 2020; 2020 Apr 21. PMID: 32373615.
Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview.Torres S, Abdullah Z, Brol MJ, Hellerbrand C, Fernandez M, Fiorotto R, Klein S, Königshofer P, Liedtke C, Lotersztajn S, Nevzorova YA, Schierwagen R, Reiberger T, Uschner FE, Tacke F, Weiskirchen R, Trebicka J. Int J Mol Sci. 2020 Mar 16; 2020 Mar 16. PMID: 32188134.
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology.Strazzabosco M, Cortesi PA, Conti S, Okolicsanyi S, Rota M, Ciaccio A, Cozzolino P, Fornari C, Gemma M, Scalone L, Cesana G, Fabris L, Colledan M, Fagiuoli S, Ideo G, Zavaglia C, Perricone G, Munari LM, Mantovani LG, Belli LS. Liver Int. 2020 Jan; 2019 Nov 12. PMID: 31654608.

2019

The challenges of primary biliary cholangitis: What is new and what needs to be done.Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME. J Autoimmun. 2019 Dec; 2019 Sep 20. PMID: 31548157.
Solar PV adoption in wastewater treatment plants: A review of practice in California.Strazzabosco A, Kenway SJ, Lant PA. J Environ Manage. 2019 Oct 15; 2019 Aug 3. PMID: 31386989.
Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma.Kokabi N, Nezami N, Xing M, Ludwig JM, Strazzabosco M, Kim HS. J Comp Eff Res. 2019 Sep; 2019 Sep 12. PMID: 31512955.
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.Fabris L, Fiorotto R, Spirli C, Cadamuro M, Mariotti V, Perugorria MJ, Banales JM, Strazzabosco M. Nat Rev Gastroenterol Hepatol. 2019 Aug. PMID: 31165788.
The tumour microenvironment and immune milieu of cholangiocarcinoma.Fabris L, Perugorria MJ, Mertens J, Björkström NK, Cramer T, Lleo A, Solinas A, Sänger H, Lukacs-Kornek V, Moncsek A, Siebenhüner A, Strazzabosco M. Liver Int. 2019 May. PMID: 30907492.
Cholangiocyte pathobiology.Banales JM, Huebert RC, Karlsen T, Strazzabosco M, LaRusso NF, Gores GJ. Nat Rev Gastroenterol Hepatol. 2019 May. PMID: 30850822.
Animal models of cholestasis: An update on inflammatory cholangiopathies.Mariotti V, Cadamuro M, Spirli C, Fiorotto R, Strazzabosco M, Fabris L. Biochim Biophys Acta Mol Basis Dis. 2019 May 1; 2018 Aug 11. PMID: 30398152.
Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M. Biochim Biophys Acta Mol Basis Dis. 2019 May 1; 2018 Sep 5. PMID: 30264693.
Animal models for cystic fibrosis liver disease (CFLD).Fiorotto R, Amenduni M, Mariotti V, Cadamuro M, Fabris L, Spirli C, Strazzabosco M. Biochim Biophys Acta Mol Basis Dis. 2019 May 1; 2018 Jul 30. PMID: 30071276.
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, Fingas C, Cristina Malerba M, Nardo G, Dall'Olmo L, Milani E, Mariotti V, Stecca T, Massani M, Spirli C, Fiorotto R, Indraccolo S, Strazzabosco M, Fabris L. J Hepatol. 2019 Apr; 2018 Dec 14. PMID: 30553841.
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wei Wang X, Zhu AX. Hepatology. 2019 Apr; 2019 Mar 25. PMID: 30251463.
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients With Advanced Hepatocellular Carcinoma.Ippolito D, Querques G, Pecorelli A, Talei Franzesi C, Okolicsanyi S, Strazzabosco M, Sironi S. J Comput Assist Tomogr. 2019 Mar/Apr. PMID: 30407241.
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data.Marcellusi A, Viti R, Kondili LA, Rosato S, Vella S, Mennini FS. Pharmacoeconomics. 2019 Feb. PMID: 30378086.
Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.Fiorotto R, Strazzabosco M. Cell Mol Gastroenterol Hepatol. 2019; 2019 May 7. PMID: 31075352.

2018

Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies.Cannito S, Milani C, Cappon A, Parola M, Strazzabosco M, Cadamuro M. Int J Mol Sci. 2018 Dec 4; 2018 Dec 4. PMID: 30518128.
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes.Mirijello A, Viazzi F, Fioretto P, Giorda C, Ceriello A, Russo GT, Guida P, Pontremoli R, De Cosmo S. BMC Nephrol. 2018 Dec 4; 2018 Dec 4. PMID: 30514308.
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?Kondili LA, Robbins S, Blach S, Gamkrelidze I, Zignego AL, Brunetto MR, Raimondo G, Taliani G, Iannone A, Russo FP, Santantonio TA, Zuin M, Chessa L, Blanc P, Puoti M, Vinci M, Erne EM, Strazzabosco M, Massari M, Lampertico P, Rumi MG, Federico A, Orlandini A, Ciancio A, Borgia G, Andreone P, Caporaso N, Persico M, Ieluzzi D, Madonia S, Gori A, Gasbarrini A, Coppola C, Brancaccio G, Andriulli A, Quaranta MG, Montilla S, Razavi H, Melazzini M, Vella S, Craxì A. Liver Int. 2018 Dec; 2018 Aug 10. PMID: 29900654.
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation.Riva G, Cilibrasi C, Bazzoni R, Cadamuro M, Negroni C, Butta V, Strazzabosco M, Dalprà L, Lavitrano M, Bentivegna A. Genes (Basel). 2018 Oct 26; 2018 Oct 26. PMID: 30373123.
Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.Belli LS, Perricone G, Adam R, Cortesi PA, Strazzabosco M, Facchetti R, Karam V, Salizzoni M, Andujar RL, Fondevila C, De Simone P, Morelli C, Fabregat-Prous J, Samuel D, Agarwaal K, Moreno Gonzales E, Charco R, Zieniewicz K, De Carlis L, Duvoux C. J Hepatol. 2018 Oct; 2018 Jun 27. PMID: 29940268.
Animal models of cholangiocarcinoma: What they teach us about the human disease.Cadamuro M, Brivio S, Stecca T, Kaffe E, Mariotti V, Milani C, Fiorotto R, Spirli C, Strazzabosco M, Fabris L. Clin Res Hepatol Gastroenterol. 2018 Oct; 2018 May 9. PMID: 29753731.
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions.Ippolito D, Querques G, Okolicsanyi S, Talei Franzesi C, Pecorelli A, Lombardi S, Orsini E, Strazzabosco M, Sironi S. Eur J Radiol. 2018 Sep; 2018 Jul 20. PMID: 30150052.
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities.Cortesi PA, Belli LS, Facchetti R, Mazzarelli C, Perricone G, De Nicola S, Cesana G, Duvoux C, Mantovani LG, Strazzabosco M. J Viral Hepat. 2018 Jul; 2018 Mar 8. PMID: 29406608.
β-Catenin and interleukin-1β-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis.Kaffe E, Fiorotto R, Pellegrino F, Mariotti V, Amenduni M, Cadamuro M, Fabris L, Strazzabosco M, Spirli C. Hepatology. 2018 May; 2018 Mar 25. PMID: 29140564.
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine.Carbone M, Cristoferi L, Cortesi PA, Rota M, Ciaccio A, Okolicsanyi S, Gemma M, Scalone L, Cesana G, Fabris L, Colledan M, Fagiuoli S, Ideo G, Belli LS, Munari LM, Mantovani L, Strazzabosco M. Biochim Biophys Acta Mol Basis Dis. 2018 Apr; 2017 Aug 24. PMID: 28844954.
The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.Cadamuro M, Stecca T, Brivio S, Mariotti V, Fiorotto R, Spirli C, Strazzabosco M, Fabris L. Biochim Biophys Acta Mol Basis Dis. 2018 Apr; 2017 Jul 27. PMID: 28757170.
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.Strazzabosco M, Fiorotto R, Cadamuro M, Spirli C, Mariotti V, Kaffe E, Scirpo R, Fabris L. Biochim Biophys Acta Mol Basis Dis. 2018 Apr; 2017 Jul 25. PMID: 28754453.
Animal models of biliary injury and altered bile acid metabolism.Mariotti V, Strazzabosco M, Fabris L, Calvisi DF. Biochim Biophys Acta Mol Basis Dis. 2018 Apr; 2017 Jul 11. PMID: 28709963.
Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.Brivio S, Cadamuro M, Fabris L, Strazzabosco M. Gene Expr. 2018 Mar 21; 2017 Oct 25. PMID: 29070148.
Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M. Hepatology. 2018 Mar; 2018 Jan 26. PMID: 28836688.

2017

Notch signaling and progenitor/ductular reaction in steatohepatitis.Morell CM, Fiorotto R, Meroni M, Raizner A, Torsello B, Cadamuro M, Spagnuolo G, Kaffe E, Sutti S, Albano E, Strazzabosco M. PLoS One. 2017; 2017 Nov 15. PMID: 29140985.
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV.Karampatou A, Han X, Kondili LA, Taliani G, Ciancio A, Morisco F, Critelli RM, Baraldi E, Bernabucci V, Troshina G, Guarino M, Tagliavini S, D'Ambrosio F, Bristot L, Turco L, Rosato S, Vella S, Trenti T, Neri I, La Marca A, Manthena S, Goldstein AS, Bruno S, Bao Y, Gonzalez YS, Villa E. J Hepatol. 2017 Sep 5; 2017 Sep 5. PMID: 28882581.
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.Belli LS, Duvoux C, Berenguer M, Berg T, Coilly A, Colle I, Fagiuoli S, Khoo S, Pageaux GP, Puoti M, Samuel D, Strazzabosco M. J Hepatol. 2017 Sep; 2017 Mar 18. PMID: 28323126.
Emerging concepts in biliary repair and fibrosis.Fabris L, Spirli C, Cadamuro M, Fiorotto R, Strazzabosco M. Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1; 2017 May 19. PMID: 28526690.
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis.Ciaccio A, Cortesi PA, Bellelli G, Rota M, Conti S, Okolicsanyi S, Rota M, Cesana G, Mantovani LG, Annoni G, Strazzabosco M. Liver Int. 2017 Jul; 2017 Mar 2. PMID: 27943549.
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study.Ippolito D, Querques G, Okolicsanyi S, Franzesi CT, Strazzabosco M, Sironi S. Eur J Radiol. 2017 May; 2017 Feb 20. PMID: 28583645.
Value-based care in hepatology.Strazzabosco M, Allen JI, Teisberg EO. Hepatology. 2017 May. PMID: 28073146.
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.Brivio S, Cadamuro M, Strazzabosco M, Fabris L. World J Hepatol. 2017 Mar 28. PMID: 28396716.
Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.Spirli C, Mariotti V, Villani A, Fabris L, Fiorotto R, Strazzabosco M. J Hepatol. 2017 Mar; 2016 Nov 5. PMID: 27826057.
Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Cadamuro M, Brivio S, Spirli C, Joplin RE, Strazzabosco M, Fabris L. Int J Mol Sci. 2017 Jan 13; 2017 Jan 13. PMID: 28098760.
Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.Cilibrasi C, Riva G, Romano G, Cadamuro M, Bazzoni R, Butta V, Paoletta L, Dalprà L, Strazzabosco M, Lavitrano M, Giovannoni R, Bentivegna A. PLoS One. 2017; 2017 Jan 12. PMID: 28081224.
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?Zavaglia C, Okolicsanyi S, Cesarini L, Mazzarelli C, Pontecorvi V, Ciaccio A, Strazzabosco M, Belli LS. J Hepatol. 2017 Jan; 2016 Aug 31. PMID: 27592303.

2016

Liver-allocation policies for patients affected by HCC in Europe.De Carlis L, Di Sandro S, Centonze L, Lauterio A, Buscemi V, De Carlis R, Ferla F, Sguinzi R, Okolicsanyi S, Belli L, Strazzabosco M. Curr Transplant Rep. 2016 Dec; 2016 Oct 7. PMID: 28473952.
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.Fiorotto R, Villani A, Kourtidis A, Scirpo R, Amenduni M, Geibel PJ, Cadamuro M, Spirli C, Anastasiadis PZ, Strazzabosco M. Hepatology. 2016 Dec; 2016 Oct 27. PMID: 27629435.
Cystic Fibrosis-Related Liver Diseases: New Paradigm for Treatment Based on Pathophysiology.Fiorotto R, Strazzabosco M. Clin Liver Dis (Hoboken). 2016 Nov; 2016 Nov 30. PMID: 31041076.
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases.Mantovani LG, Cortesi PA, Strazzabosco M. Hepatology. 2016 Oct; 2016 Apr 4. PMID: 26926906.
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study.Belli LS, Berenguer M, Cortesi PA, Strazzabosco M, Rockenschaub SR, Martini S, Morelli C, Donato F, Volpes R, Pageaux GP, Coilly A, Fagiuoli S, Amaddeo G, Perricone G, Vinaixa C, Berlakovich G, Facchetti R, Polak W, Muiesan P, Duvoux C. J Hepatol. 2016 Sep; 2016 May 17. PMID: 27212241.
Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.Cadamuro M, Spagnuolo G, Sambado L, Indraccolo S, Nardo G, Rosato A, Brivio S, Caslini C, Stecca T, Massani M, Bassi N, Novelli E, Spirli C, Fabris L, Strazzabosco M. Cancer Res. 2016 Aug 15; 2016 Jun 21. PMID: 27328733.
Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis.Locatelli L, Cadamuro M, Spirlì C, Fiorotto R, Lecchi S, Morell CM, Popov Y, Scirpo R, De Matteis M, Amenduni M, Pietrobattista A, Torre G, Schuppan D, Fabris L, Strazzabosco M. Hepatology. 2016 Mar; 2016 Jan 16. PMID: 26645994.
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype.Fabris L, Brivio S, Cadamuro M, Strazzabosco M. Stem Cells Int. 2016; 2016 Jan 6. PMID: 26880950.

2015

Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Brivio S, Cadamuro M, Fabris L, Strazzabosco M. J Clin Med. 2015 Dec 19; 2015 Dec 19. PMID: 26703747.
Posttranslational regulation of polycystin-2 protein expression as a novel mechanism of cholangiocyte reaction and repair from biliary damage.Spirli C, Villani A, Mariotti V, Fabris L, Fiorotto R, Strazzabosco M. Hepatology. 2015 Dec; 2015 Oct 10. PMID: 26313562.
Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium.Scirpo R, Fiorotto R, Villani A, Amenduni M, Spirli C, Strazzabosco M. Hepatology. 2015 Nov; 2015 Aug 28. PMID: 26199136.
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D, Gershwin ME, Anderson CA, Lazaridis KN, Invernizzi P, Seldin MF, Sandford RN, Amos CI, Siminovitch KA. Nat Commun. 2015 Sep 22; 2015 Sep 22. PMID: 26394269.
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.Morton SD, Cadamuro M, Brivio S, Vismara M, Stecca T, Massani M, Bassi N, Furlanetto A, Joplin RE, Floreani A, Fabris L, Strazzabosco M. Oncotarget. 2015 Sep 22. PMID: 26296968.
Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort.Belli LS, Romagnoli R, Nardi A, Marianelli T, Donato F, Corradini SG, Iemmolo RM, Morelli C, Pasulo L, Rendina M, De Martin E, Ponziani FR, Volpes R, Strazzabosco M, Angelico M. Dig Liver Dis. 2015 Aug; 2015 Apr 16. PMID: 26055490.
Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.Cortesi PA, Mantovani LG, Ciaccio A, Rota M, Mazzarelli C, Cesana G, Strazzabosco M, Belli LS. Am J Transplant. 2015 Jul. PMID: 26086300.
Ezrin finds its groove in cholangiocytes.Fouassier L, Fiorotto R. Hepatology. 2015 May; 2015 Mar 19. PMID: 25545157.
Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.Lapolla A, Frison V, Bettio M, Dal Pos M, Rocchini P, Panebianco G, Tadiotto F, Da Tos V, D'Ambrosio M, Marangoni A, Ferrari M, Pianta A, Balzano S, Confortin L, Lamonica M, Marin N, Strazzabosco M, Brun E, Mesturino CA, Simoncini M, Zen F, Bax G, Bonsembiante B, Cardone C, Dal Frà MG, Gallo A, Masin M, Piarulli F, Sartore G, Simioni N. Clin Ther. 2015 Mar 1; 2015 Jan 24. PMID: 25626486.
Continuous subcutaneous insulin infusion in Italy: third national survey.Bruttomesso D, Laviola L, Lepore G, Bonfanti R, Bozzetto L, Corsi A, Di Blasi V, Girelli A, Grassi G, Iafusco D, Rabbone I, Schiaffini R. Diabetes Technol Ther. 2015 Feb; 2014 Dec 5. PMID: 25479035.
Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.Cortesi PA, Ciaccio A, Rota M, Lim JK, De Salvia S, Okolicsanyi S, Vinci M, Belli LS, Mantovani LG, Strazzabosco M. J Viral Hepat. 2015 Feb; 2014 Jul 10. PMID: 25040391.
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.Bonato G, Cristoferi L, Strazzabosco M, Fabris L. Dig Dis. 2015; 2015 Dec 7. PMID: 26641079.
Emerging roles of Notch signaling in liver disease.Geisler F, Strazzabosco M. Hepatology. 2015 Jan; 2014 Sep 19. PMID: 24930574.

2014

A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases.Cortesi PA, Rota M, Scalone L, Cozzolino P, Cesana G, Mantovani L, Okolicsanyi S, Ciaccio A, Gemma M, Fagiuoli S, Valsecchi MG, Belli LS, Strazzabosco M. Value Health. 2014 Nov; 2014 Oct 26. PMID: 27200782.
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation.Cortesi PA, Mantovani L, Ciaccio A, Rota M, Cesana G, Strazzabosco M, Belli LS. Value Health. 2014 Nov; 2014 Oct 26. PMID: 27200773.
Osteopontin: a new player in regulating hepatic ductular reaction and hepatic progenitor cell responses during chronic liver injury.Strazzabosco M, Fabris L, Albano E. Gut. 2014 Nov; 2014 Jul 23. PMID: 25056656.
Neural cell adhesion molecule and polysialic acid in ductular reaction: the puzzle is far from completed, but the picture is becoming more clear.Strazzabosco M, Fabris L. Hepatology. 2014 Nov; 2014 Oct 1. PMID: 24995463.
Characterization of animal models for primary sclerosing cholangitis (PSC).Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, Keitel V, Schramm C, Marschall HU, Karlsen TH, Melum E, Kaser A, Eksteen B, Strazzabosco M, Manns M, Trauner M. J Hepatol. 2014 Jun; 2014 Feb 19. PMID: 24560657.
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.Angelico M, Nardi A, Romagnoli R, Marianelli T, Corradini SG, Tandoi F, Gavrila C, Salizzoni M, Pinna AD, Cillo U, Gridelli B, De Carlis LG, Colledan M, Gerunda GE, Costa AN, Strazzabosco M. Dig Liver Dis. 2014 Apr; 2014 Jan 9. PMID: 24411484.
Notch signaling and new therapeutic options in liver disease.Morell CM, Strazzabosco M. J Hepatol. 2014 Apr; 2013 Dec 3. PMID: 24308992.
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes.De Cosmo S, Rossi MC, Pellegrini F, Lucisano G, Bacci S, Gentile S, Ceriello A, Russo G, Nicolucci A, Giorda C, Viazzi F, Pontremoli R. Nephrol Dial Transplant. 2014 Mar; 2014 Jan 6. PMID: 24398892.

2013

Notch signalling beyond liver development: emerging concepts in liver repair and oncogenesis.Morell CM, Fiorotto R, Fabris L, Strazzabosco M. Clin Res Hepatol Gastroenterol. 2013 Nov; 2013 Jun 24. PMID: 23806629.
Protein kinase A-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis.Spirli C, Locatelli L, Morell CM, Fiorotto R, Morton SD, Cadamuro M, Fabris L, Strazzabosco M. Hepatology. 2013 Nov; 2013 Sep 30. PMID: 23744610.
Healthcare costs associated with hepatocellular carcinoma and the value of care.Mantovani LG, Strazzabosco M. Hepatology. 2013 Oct; 2013 Aug 13. PMID: 23913793.
Long term outcome of acute pancreatitis in Italy: results of a multicentre study.Castoldi L, De Rai P, Zerbi A, Frulloni L, Uomo G, Gabbrielli A, Bassi C, Pezzilli R. Dig Liver Dis. 2013 Oct; 2013 Jul 3. PMID: 23831129.
Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial.Bosi E, Scavini M, Ceriello A, Cucinotta D, Tiengo A, Marino R, Bonizzoni E, Giorgino F. Diabetes Care. 2013 Oct; 2013 Jun 4. PMID: 23735724.
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.Massani M, Stecca T, Fabris L, Caratozzolo E, Ruffolo C, Furlanetto A, Morton S, Cadamuro M, Strazzabosco M, Bassi N. Oncol Rep. 2013 Sep; 2013 Jun 26. PMID: 23807641.
EASL recognition awardee 2013: Professor Jesus Prieto.Strazzabosco M. J Hepatol. 2013 Sep; 2013 Jun 10. PMID: 23764136.
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.Cadamuro M, Nardo G, Indraccolo S, Dall'olmo L, Sambado L, Moserle L, Franceschet I, Colledan M, Massani M, Stecca T, Bassi N, Morton S, Spirli C, Fiorotto R, Fabris L, Strazzabosco M. Hepatology. 2013 Sep; 2013 Jul 22. PMID: 23505219.
Vascular biology of the biliary epithelium.Morell CM, Fabris L, Strazzabosco M. J Gastroenterol Hepatol. 2013 Aug. PMID: 23855292.
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: the egg of columbus or another illusion?Kim AK, Dziura J, Strazzabosco M. Hepatology. 2013 Aug. PMID: 23703812.
Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.Cadamuro M, Morton SD, Strazzabosco M, Fabris L. Transl Gastrointest Cancer. 2013 Jul. PMID: 28989865.
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice.Fiorotto R, Raizner A, Morell CM, Torsello B, Scirpo R, Fabris L, Spirli C, Strazzabosco M. J Hepatol. 2013 Jul; 2013 Mar 7. PMID: 23500150.
Vascular endothelial growth factors in progenitor cells mediated liver repair.Spirli C, Strazzabosco M. Hepatobiliary Surg Nutr. 2013 Apr. PMID: 24570918.
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies.Kar SP, Seldin MF, Chen W, Lu E, Hirschfield GM, Invernizzi P, Heathcote J, Cusi D, Gershwin ME, Siminovitch KA, Amos CI. Genes Immun. 2013 Apr; 2013 Feb 7. PMID: 23392275.
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN. J Hepatol. 2013 Apr; 2012 Nov 28. PMID: 23201239.
Toward a rational management of very early hepatocellular carcinoma.Strazzabosco M. Hepatology. 2013 Apr; 2013 Mar 6. PMID: 22987787.
The balance between Notch/Wnt signaling regulates progenitor cells' commitment during liver repair: mystery solved?Strazzabosco M, Fabris L. J Hepatol. 2013 Jan; 2012 Aug 15. PMID: 22902547.

2012

Notch signaling in hepatocellular carcinoma: guilty in association!Strazzabosco M, Fabris L. Gastroenterology. 2012 Dec; 2012 Oct 22. PMID: 23099244.
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, Kosoy R, Ransom M, Sun Y, Bianchi I, Schlicht EM, Lleo A, Coltescu C, Bernuzzi F, Podda M, Lammert C, Shigeta R, Chan LL, Balschun T, Marconi M, Cusi D, Heathcote EJ, Mason AL, Myers RP, Milkiewicz P, Odin JA, Luketic VA, Bacon BR, Bodenheimer HC Jr, Liakina V, Vincent C, Levy C, Franke A, Gregersen PK, Bossa F, Gershwin ME, deAndrade M, Amos CI, Lazaridis KN, Seldin MF, Siminovitch KA. Hum Mol Genet. 2012 Dec 1; 2012 Aug 29. PMID: 22936693.
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.Spirli C, Morell CM, Locatelli L, Okolicsanyi S, Ferrero C, Kim AK, Fabris L, Fiorotto R, Strazzabosco M. Hepatology. 2012 Dec; 2012 Aug 27. PMID: 22653837.
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis.Invernizzi P, Ransom M, Raychaudhuri S, Kosoy R, Lleo A, Shigeta R, Franke A, Bossa F, Amos CI, Gregersen PK, Siminovitch KA, Cusi D, de Bakker PI, Podda M, Gershwin ME, Seldin MF. Genes Immun. 2012 Sep; 2012 May 10. PMID: 22573116.
Development of the bile ducts: essentials for the clinical hepatologist.Strazzabosco M, Fabris L. J Hepatol. 2012 May; 2012 Jan 13. PMID: 22245898.
Occurrence and predictors of employment after traumatic spinal cord injury: the GISEM Study.Franceschini M, Pagliacci MC, Russo T, Felzani G, Aito S, Marini C. Spinal Cord. 2012 Mar; 2011 Nov 29. PMID: 22124342.
Altered store operated calcium entry increases cyclic 3',5'-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes.Spirli C, Locatelli L, Fiorotto R, Morell CM, Fabris L, Pozzan T, Strazzabosco M. Hepatology. 2012 Mar. PMID: 21987453.

2011

"The city of Hepar": rituals, gastronomy, and politics at the origins of the modern names for the liver.Riva MA, Riva E, Spicci M, Strazzabosco M, Giovannini M, Cesana G. J Hepatol. 2011 Nov; 2011 Jun 28. PMID: 21718666.
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO⁻₃ output.Baghdasaryan A, Claudel T, Gumhold J, Silbert D, Adorini L, Roda A, Vecchiotti S, Gonzalez FJ, Schoonjans K, Strazzabosco M, Fickert P, Trauner M. Hepatology. 2011 Oct. PMID: 22006858.
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.Fiorotto R, Scirpo R, Trauner M, Fabris L, Hoque R, Spirli C, Strazzabosco M. Gastroenterology. 2011 Oct; 2011 Jun 26. PMID: 21712022.
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.Fabris L, Cadamuro M, Moserle L, Dziura J, Cong X, Sambado L, Nardo G, Sonzogni A, Colledan M, Furlanetto A, Bassi N, Massani M, Cillo U, Mescoli C, Indraccolo S, Rugge M, Okolicsanyi L, Strazzabosco M. Hepatology. 2011 Sep 2. PMID: 21618579.
Polycystic liver diseases: congenital disorders of cholangiocyte signaling.Strazzabosco M, Somlo S. Gastroenterology. 2011 Jun; 2011 Apr 22. PMID: 21515270.
Systemic therapy in hepatocellular carcinoma.Wrzesinski SH, Taddei TH, Strazzabosco M. Clin Liver Dis. 2011 May. PMID: 21689622.
Epithelial-mesenchymal interactions in biliary diseases.Fabris L, Strazzabosco M. Semin Liver Dis. 2011 Feb; 2011 Feb 22. PMID: 21344348.
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A, Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M, Cuomo O, De Carlis L, Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L, Mazzaferro V, Pinna A, Risaliti A, Salizzoni M, Tisone G, Valente U, Rossi G, Rossi M, Zamboni F. Dig Liver Dis. 2011 Feb; 2010 Dec 24. PMID: 21185796.
[AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care].Epidemiol Prev. 2011 Jan-Feb. PMID: 21436491.
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C.Svegliati-Baroni G, Faraci G, Fabris L, Saccomanno S, Cadamuro M, Pierantonelli I, Trozzi L, Bugianesi E, Guido M, Strazzabosco M, Benedetti A, Marchesini G. Gut. 2011 Jan; 2010 Oct 21. PMID: 20966027.
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.Alvaro D, Bragazzi MC, Benedetti A, Fabris L, Fava G, Invernizzi P, Marzioni M, Nuzzo G, Strazzabosco M, Stroffolini T. Dig Liver Dis. 2011 Jan; 2010 Jun 26. PMID: 20580332.

2010

Surgical management of acute pancreatitis in Italy: lessons from a prospective multicentre study.De Rai P, Zerbi A, Castoldi L, Bassi C, Frulloni L, Uomo G, Gabbrielli A, Pezzilli R, Cavallini G, Di Carlo V. HPB (Oxford). 2010 Nov; 2010 Sep 2. PMID: 20961367.
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis.Liu X, Invernizzi P, Lu Y, Kosoy R, Lu Y, Bianchi I, Podda M, Xu C, Xie G, Macciardi F, Selmi C, Lupoli S, Shigeta R, Ransom M, Lleo A, Lee AT, Mason AL, Myers RP, Peltekian KM, Ghent CN, Bernuzzi F, Zuin M, Rosina F, Borghesio E, Floreani A, Lazzari R, Niro G, Andriulli A, Muratori L, Muratori P, Almasio PL, Andreone P, Margotti M, Brunetto M, Coco B, Alvaro D, Bragazzi MC, Marra F, Pisano A, Rigamonti C, Colombo M, Marzioni M, Benedetti A, Fabris L, Strazzabosco M, Portincasa P, Palmieri VO, Tiribelli C, Croce L, Bruno S, Rossi S, Vinci M, Prisco C, Mattalia A, Toniutto P, Picciotto A, Galli A, Ferrari C, Colombo S, Casella G, Morini L, Caporaso N, Colli A, Spinzi G, Montanari R, Gregersen PK, Heathcote EJ, Hirschfield GM, Siminovitch KA, Amos CI, Gershwin ME, Seldin MF. Nat Genet. 2010 Aug; 2010 Jul 18. PMID: 20639880.
Descriptive epidemiology of cholangiocarcinoma in Italy.Alvaro D, Crocetti E, Ferretti S, Bragazzi MC, Capocaccia R. Dig Liver Dis. 2010 Jul; 2009 Dec 22. PMID: 20022823.
Foxa1 and Foxa2 regulate bile duct development in mice.Strazzabosco M. J Hepatol. 2010 May; 2010 Feb 18. PMID: 20347503.
Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.Hov JR, Lleo A, Selmi C, Woldseth B, Fabris L, Strazzabosco M, Karlsen TH, Invernizzi P. J Hepatol. 2010 May; 2010 Mar 4. PMID: 20347497.
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M. Hepatology. 2010 May. PMID: 20131403.
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria.De Giorgio M, Vezzoli S, Cohen E, Armellini E, Lucà MG, Verga G, Pinelli D, Nani R, Valsecchi MG, Antolini L, Colledan M, Fagiuoli S, Strazzabosco M. Liver Transpl. 2010 Apr. PMID: 20373461.
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M. Gastroenterology. 2010 Jan; 2009 Sep 18. PMID: 19766642.

2009

Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation.Strazzabosco M, Fiorotto R, Melero S, Glaser S, Francis H, Spirli C, Alpini G. Hepatology. 2009 Jul. PMID: 19444869.
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.Halilbasic E, Fiorotto R, Fickert P, Marschall HU, Moustafa T, Spirli C, Fuchsbichler A, Gumhold J, Silbert D, Zatloukal K, Langner C, Maitra U, Denk H, Hofmann AF, Strazzabosco M, Trauner M. Hepatology. 2009 Jun. PMID: 19475687.
The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa.Debellis L, Diana A, Arcidiacono D, Fiorotto R, Portincasa P, Altomare DF, Spirlì C, de Bernard M. PLoS One. 2009; 2009 Mar 31. PMID: 19333391.
Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes.Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S, Vitali L, Bulotta A, Nicoziani P, Coronel G. Nutr Metab Cardiovasc Dis. 2009 Jan; 2008 May 1. PMID: 18450436.

2008

Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls.Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, Almasio P, Rosina F, Marzioni M, Fabris L, Muratori L, Qi L, Seldin MF, Gershwin ME, Podda M. Hepatology. 2008 Dec. PMID: 19003916.
Hospital care of postacute spinal cord lesion patients in Italy: analysis of readmissions into the GISEM study.Pagliacci MC, Celani MG, Spizzichino L, Zampolini M, Franceschini M. Am J Phys Med Rehabil. 2008 Aug. PMID: 18209666.
Incidence and management of colorectal cancer in liver transplant recipients.Nishihori T, Strazzabosco M, Saif MW. Clin Colorectal Cancer. 2008 Jul. PMID: 18650194.
Type I autoimmune hepatitis presenting with acute liver failure in the setting of wild mushroom ingestion.Rogart JN, Iyer A, Robert ME, Levy G, Strazzabosco M. J Clin Gastroenterol. 2008 Jul. PMID: 18496396.
Functional anatomy of normal bile ducts.Strazzabosco M, Fabris L. Anat Rec (Hoboken). 2008 Jun. PMID: 18484611.
Prognostic prediction in hepatocellular carcinoma: from art to science.Strazzabosco M, Cohen E, Emre S. J Clin Gastroenterol. 2008 Mar. PMID: 18223506.
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.Alvaro D, Onori P, Alpini G, Franchitto A, Jefferson DM, Torrice A, Cardinale V, Stefanelli F, Mancino MG, Strazzabosco M, Angelico M, Attili A, Gaudio E. Am J Pathol. 2008 Feb; 2008 Jan 17. PMID: 18202196.
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development.Fabris L, Cadamuro M, Libbrecht L, Raynaud P, Spirlì C, Fiorotto R, Okolicsanyi L, Lemaigre F, Strazzabosco M, Roskams T. Hepatology. 2008 Feb. PMID: 18157837.

2007

Integration of blood volume, blood pressure, heart rate and bioimpedance monitoring for the achievement of optimal dry body weight during chronic hemodialysis.Bonello M, House AA, Cruz D, Asuman Y, Andrikos E, Petras D, Strazzabosco M, Ronco F, Brendolan A, Crepaldi C, Nalesso F, Ronco C. Int J Artif Organs. 2007 Dec. PMID: 18203072.
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion.Fiorotto R, Spirlì C, Fabris L, Cadamuro M, Okolicsanyi L, Strazzabosco M. Gastroenterology. 2007 Nov; 2007 Sep 2. PMID: 17983806.
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass.Corno V, Dezza MC, Lucianetti A, Codazzi D, Carrara B, Pinelli D, Parigi PC, Guizzetti M, Strazzabosco M, Melzi ML, Gaffuri G, Sonzogni V, Rossi A, Fagiuoli S, Colledan M. Am J Transplant. 2007 Oct. PMID: 17845577.
Hepatic venous pressure gradient (HVPG), serum sodium (SNa), and model of end-stage liver disease score (MELD): prognostic significance and correlations.Taddei TH, Strazzabosco M. J Clin Gastroenterol. 2007 Aug. PMID: 17667045.
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.Fabris L, Cadamuro M, Guido M, Spirli C, Fiorotto R, Colledan M, Torre G, Alberti D, Sonzogni A, Okolicsanyi L, Strazzabosco M. Am J Pathol. 2007 Aug; 2007 Jun 28. PMID: 17600123.
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.Angelico M, Petrolati A, Lionetti R, Lenci I, Burra P, Donato MF, Merli M, Strazzabosco M, Tisone G. J Hepatol. 2007 Jun; 2007 Feb 5. PMID: 17328985.
Synthesis and cytotoxicity properties of amiodarone analogues.Bigler L, Spirli C, Fiorotto R, Pettenazzo A, Duner E, Baritussio A, Follath F, Ha HR. Eur J Med Chem. 2007 Jun; 2007 Jan 14. PMID: 17316909.
Inheritance of hyperbilirubinemia: evidence for a major autosomal recessive gene.Clementi M, Di Gianantonio E, Fabris L, Forabosco P, Strazzabosco M, Tenconi R, Okolicsanyi L. Dig Liver Dis. 2007 Apr; 2007 Mar 7. PMID: 17347060.
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient.Montalbano M, Pasulo L, Sonzogni A, Remuzzi G, Colledan M, Strazzabosco M. J Clin Gastroenterol. 2007 Feb. PMID: 17245223.

2006

Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry.Melzi ML, Kelly DA, Colombo C, Jara P, Manzanares J, Colledan M, Strazzabosco M, DeLorenzo P, Valsecchi MG, Adam R, Gridelli B, Assael BM. Transpl Int. 2006 Sep. PMID: 16918533.
Extended right split liver graft for primary transplantation in children and adults.Corno V, Colledan M, Dezza MC, Guizzetti M, Lucianetti A, Maldini G, Pinelli D, Giovanelli M, Zambelli M, Torre G, Strazzabosco M. Transpl Int. 2006 Jun. PMID: 16771871.
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.Fabris L, Cadamuro M, Fiorotto R, Roskams T, Spirlì C, Melero S, Sonzogni A, Joplin RE, Okolicsanyi L, Strazzabosco M. Hepatology. 2006 May. PMID: 16628643.

2005

[Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].Rossini R, Lucà MG, Scuri P, Invernizzi P, Strazzabosco M, Gavazzi A. Ital Heart J Suppl. 2005 Oct. PMID: 16273749.
Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis.Marra F, DeFranco R, Robino G, Novo E, Efsen E, Pastacaldi S, Zamara E, Vercelli A, Lottini B, Spirli C, Strazzabosco M, Pinzani M, Parola M. World J Gastroenterol. 2005 Aug 28. PMID: 16124041.
Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism.Spirlì C, Fiorotto R, Song L, Santos-Sacchi J, Okolicsanyi L, Masier S, Rocchi L, Vairetti MP, De Bernard M, Melero S, Pozzan T, Strazzabosco M. Gastroenterology. 2005 Jul. PMID: 16012949.
Practice of adult liver transplantation in Italy. Recommendations of the Italian Association for the Study of the Liver (A.I.S.F.).Angelico M, Gridelli B, Strazzabosco M. Dig Liver Dis. 2005 Jul. PMID: 15893508.
Pathophysiology of cholangiopathies.Strazzabosco M, Fabris L, Spirli C. J Clin Gastroenterol. 2005 Apr. PMID: 15758666.
Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants.Spada M, Cescon M, Aluffi A, Zambelli M, Guizzetti M, Lucianetti A, Pinelli D, Strazzabosco M, Gridelli B, Colledan M. Transplant Proc. 2005 Mar. PMID: 15848657.

2004

The cholangiopathies: disorders of biliary epithelia.Lazaridis KN, Strazzabosco M, Larusso NF. Gastroenterology. 2004 Nov. PMID: 15521023.
Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.Barone M, Maiorano E, Ladisa R, Pece A, Berloco P, Strazzabosco M, Caruso ML, Valentini AM, Ierardi E, Di Leo A, Francavilla A. Virchows Arch. 2004 Jun; 2004 Apr 8. PMID: 15071740.
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests.Sonzogni A, Colloredo G, Fabris L, Cadamuro M, Paris B, Roffi L, Pozzi M, Bovo G, Del Poggio P, Portmann BC, Strazzabosco M. J Hepatol. 2004 Apr. PMID: 15030974.

2003

Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population.Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M, Floreani A, Rosina F, Bianchi Porro G, Strazzabosco M, Okolicsanyi L. Dig Liver Dis. 2003 Aug. PMID: 14567462.
Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes.Spirlì C, Fabris L, Duner E, Fiorotto R, Ballardini G, Roskams T, Larusso NF, Sonzogni A, Okolicsanyi L, Strazzabosco M. Gastroenterology. 2003 Mar. PMID: 12612912.

2002

Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.Petz W, Spada M, Bertani A, Lucianctti A, Casagrande F, Guizzetti M, Corno V, Colledan M, Strazzabosco M, Gridelli B. Transplant Proc. 2002 Aug. PMID: 12176648.
Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial.Volpin R, Angeli P, Galioto A, Fasolato S, Neri D, Barbazza F, Merenda R, Del Piccolo F, Strazzabosco M, Casagrande F, Feltracco P, Sticca A, Merkel C, Gerunda G, Gatta A. Liver Transpl. 2002 Jun. PMID: 12037783.
Defective regulation of cholangiocyte Cl-/HCO3(-) and Na+/H+ exchanger activities in primary biliary cirrhosis.Melero S, Spirlì C, Zsembery A, Medina JF, Joplin RE, Duner E, Zuin M, Neuberger JM, Prieto J, Strazzabosco M. Hepatology. 2002 Jun. PMID: 12029638.
Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.Ballardini G, De Raffele E, Groff P, Bioulac-Sage P, Grassi A, Ghetti S, Susca M, Strazzabosco M, Bellusci R, Iemmolo RM, Grazi G, Zauli D, Cavallari A, Bianchi FB. Liver Transpl. 2002 Jan. PMID: 11799480.
Correction of CFTR malfunction and stimulation of Ca-activated Cl channels restore HCO3- secretion in cystic fibrosis bile ductular cells.Zsembery A, Jessner W, Sitter G, Spirlí C, Strazzabosco M, Graf J. Hepatology. 2002 Jan. PMID: 11786964.

2001

Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.Pellizzer G, Strazzabosco M, Presi S, Furlan F, Lora L, Benedetti P, Bonato M, Erle G, de Lalla F. Diabet Med. 2001 Oct. PMID: 11678973.
Ductular morphogenesis and functional polarization of normal human biliary epithelial cells in three-dimensional culture.Ishida Y, Smith S, Wallace L, Sadamoto T, Okamoto M, Auth M, Strazzabosco M, Fabris L, Medina J, Prieto J, Strain A, Neuberger J, Joplin R. J Hepatol. 2001 Jul. PMID: 11495037.
Proinflammatory cytokines inhibit secretion in rat bile duct epithelium.Spirlì C, Nathanson MH, Fiorotto R, Duner E, Denson LA, Sanz JM, Di Virgilio F, Okolicsanyi L, Casagrande F, Strazzabosco M. Gastroenterology. 2001 Jul. PMID: 11438505.
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.de Lalla F, Pellizzer G, Strazzabosco M, Martini Z, Du Jardin G, Lora L, Fabris P, Benedetti P, Erle G. Antimicrob Agents Chemother. 2001 Apr. PMID: 11257020.

2000

Ca2+-activated Cl- channels can substitute for CFTR in stimulation of pancreatic duct bicarbonate secretion.Zsembery A, Strazzabosco M, Graf J. FASEB J. 2000 Nov. PMID: 11053257.
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations.Fabris L, Strazzabosco M, Crosby HA, Ballardini G, Hubscher SG, Kelly DA, Neuberger JM, Strain AJ, Joplin R. Am J Pathol. 2000 May. PMID: 10793072.
Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.Colombo C, Okolicsanyi L, Strazzabosco M. Dig Liver Dis. 2000 Mar. PMID: 10975791.
Pathophysiology of the intrahepatic biliary epithelium.Strazzabosco M, Spirlí C, Okolicsanyi L. J Gastroenterol Hepatol. 2000 Mar. PMID: 10764023.

1999

The monoethylglycinexylidide test for grading of liver cirrhosis.Fabris L, Jemmolo RM, Toffolo G, Paleari D, Viaggi S, Rigon M, Casagrande F, Lirussi F, Strazzabosco M, Cobelli C, Okolicsanyi L. Aliment Pharmacol Ther. 1999 Jan. PMID: 9892881.

1998

Functional polarity of Na+/H+ and Cl-/HCO3- exchangers in a rat cholangiocyte cell line.Spirlì C, Granato A, Zsembery K, Anglani F, Okolicsányi L, LaRusso NF, Crepaldi G, Strazzabosco M. Am J Physiol. 1998 Dec. PMID: 9843758.
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines.Zsembery A, Spirlì C, Granato A, LaRusso NF, Okolicsanyi L, Crepaldi G, Strazzabosco M. Hepatology. 1998 Oct. PMID: 9755225.
Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery.Iemmolo RM, Rossanese A, Rotilio A, Mattisi G, Gerunda GE, Merenda R, Neri D, Crepaldi G, Strazzabosco M. J Hepatol. 1998 Mar. PMID: 9551693.
Liver and biliary problems in cystic fibrosis.Colombo C, Battezzati PM, Strazzabosco M, Podda M. Semin Liver Dis. 1998. PMID: 9773423.

1997

New insights into cholangiocyte physiology.Strazzabosco M. J Hepatol. 1997 Nov. PMID: 9382988.
Transport systems in cholangiocytes: their role in bile formation and cholestasis.Strazzabosco M. Yale J Biol Med. 1997 Jul-Aug. PMID: 9626763.
Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients.Strazzabosco M, Corneo B, Iemmolo RM, Menin C, Gerunda G, Bonaldi L, Merenda R, Neri D, Poletti A, Montagna M, Del Mistro A, Faccioli AM, D'Andrea E. J Hepatol. 1997 Apr. PMID: 9126809.
Na(+)-dependent and -independent Cl-/HCO-3 exchange mediate cellular HCO3- transport in cultured human intrahepatic bile duct cells.Strazzabosco M, Joplin R, Zsembery A, Wallace L, Spirlì C, Fabris L, Granato A, Rossanese A, Poci C, Neuberger JM, Okolicsànyi L, Crepaldi G. Hepatology. 1997 Apr. PMID: 9096607.

1996

Regulation of intracellular pH in the hepatocyte. Mechanisms and physiological implications.Strazzabosco M, Boyer JL. J Hepatol. 1996 May. PMID: 8773922.
Electrolyte transport in bile ductular epithelial cells.Strazzabosco M, Zsembery A, Fabris L. J Hepatol. 1996. PMID: 8926371.

1995

Intracellular pH regulation in Hep G2 cells: effects of epidermal growth factor, transforming growth factor-alpha, and insulinlike growth factor-II on Na+/H+ exchange activity.Strazzabosco M, Poci C, Spirlì C, Zsembery A, Granato A, Massimino ML, Crepaldi G. Hepatology. 1995 Aug. PMID: 7635429.
Haemophilia treatment centres: old and new challenges.Gaynor S, Aledort L, Hilgartner M, Lipton R, Saidi P, Strazzabosco J, Phatak P, Pratok P [corrected to Phatak P]. Lancet. 1995 Mar 11. PMID: 7898206.

1994

Regulation of activity and apical targeting of the Cl-/HCO3- exchanger in rat hepatocytes.Benedetti A, Strazzabosco M, Ng OC, Boyer JL. Proc Natl Acad Sci U S A. 1994 Jan 18. PMID: 8290601.
Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line.Strazzabosco M, Poci C, Spirlí C, Sartori L, Knuth A, Crepaldi G. Hepatology. 1994 Jan. PMID: 8276351.

1993

Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL.Bruck R, Benedetti A, Strazzabosco M, Boyer JL. Am J Physiol. 1993 Aug. PMID: 8368316.
Unconjugated hyperbilirubinemia. Clinical, laboratory and metabolic aspects.Okolicsányi L, Nassuato G, Strazzabosco M, Toso T. Z Gastroenterol. 1993 Feb. PMID: 7483724.

1991

A study on the hyperinsulinism of late pregnancy.Piva I, Erle G, Thiella M, Lora L, Strazzabosco M, Sicolo N, Federspil G. J Endocrinol Invest. 1991 Nov. PMID: 1802920.
Cl(-)-HCO3- exchanger in isolated rat hepatocytes: role in regulation of intracellular pH.Benedetti A, Strazzabosco M, Corasanti JG, Haddad P, Graf J, Boyer JL. Am J Physiol. 1991 Sep. PMID: 1887897.
Intracellular pH regulation in isolated rat bile duct epithelial cells.Strazzabosco M, Mennone A, Boyer JL. J Clin Invest. 1991 May. PMID: 2022723.
Effect of Silibinin on biliary lipid composition. Experimental and clinical study.Nassuato G, Iemmolo RM, Strazzabosco M, Lirussi F, Deana R, Francesconi MA, Muraca M, Passera D, Fragasso A, Orlando R. J Hepatol. 1991 May. PMID: 1940257.
The use of isolated rat hepatocyte couplets, microscopic optical planimetry and quantitative microfluorimetry in hepatobiliary physiology.Strazzabosco M, Boyer JL, Crepaldi G. Cytotechnology. 1991 Feb. PMID: 22358966.
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers.Strazzabosco M, Sakisaka S, Hayakawa T, Boyer JL. Am J Physiol. 1991 Jan. PMID: 1987808.

1990

Effect of age on single- and multiple-dose pharmacokinetics of erythromycin.Miglioli PA, Pivetta P, Strazzabosco M, Orlando R, Okolicsanyi L, Palatini P. Eur J Clin Pharmacol. 1990. PMID: 2253666.

1989

Quantitative assessment of canalicular bile formation in isolated hepatocyte couplets using microscopic optical planimetry.Gautam A, Ng OC, Strazzabosco M, Boyer JL. J Clin Invest. 1989 Feb. PMID: 2913052.

1988

Epidemiology of unconjugated hyperbilirubinemia: revisited.Okolicsanyi L, Nassuato G, Muraca M, Orlando R, Iemmolo RM, Lirussi F, Strazzabosco M. Semin Liver Dis. 1988 May. PMID: 3051412.

1986

The effect of drugs on bile flow and composition. An overview.Okolicsanyi L, Lirussi F, Strazzabosco M, Jemmolo RM, Orlando R, Nassuato G, Muraca M, Crepaldi G. Drugs. 1986 May. PMID: 2872047.

1985

Pharmacokinetics of Josamycin in patients with liver cirrhosis and Gilbert's syndrome after repeated doses.Okolicsanyi L, Venuti M, Strazzabosco M, Biral A, Orlando R, Iemmolo RM, Nassuato G, Muraca M, Padrini G, Miglioli PA. Int J Clin Pharmacol Ther Toxicol. 1985 Aug. PMID: 4044077.

1984

Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis.Okolicsanyi L, Venuti M, Strazzabosco M, Orlando R, Nassuato G, Iemmolo RM, Lirussi F, Muraca M, Pastorino AM, Castelli G. Int J Clin Pharmacol Ther Toxicol. 1984 Jun. PMID: 6086536.
The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.Okolicsányi L, Venuti M, Strazzabosco M, Iemmolo RM, Nassuato G, Orlando R, Lirussi F. Acta Physiol Hung. 1984. PMID: 6099684.

1983

Effect of Silybin on biliary lipid composition in rats.Nassuato G, Iemmolo RM, Lirussi F, Orlando R, Giacon L, Venuti M, Strazzabosco M, Csomos G, Okolicsanyi L. Pharmacol Res Commun. 1983 Apr. PMID: 6867072.